Williams Jones Wealth Management, Llc. Vertex Pharmaceuticals Inc Transaction History

Williams Jones Wealth Management, Llc.

$8.37 Billion
Q3 2024

A detailed history of Williams Jones Wealth Management, Llc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Williams Jones Wealth Management, Llc. holds 1,135 shares of VRTX stock, worth $463,942. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,135

Previous 1,151 1.39%

Holding current value

$463,942

Previous $539,000 2.23%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $7,360 - $8,092	-16 Reduced 1.39%	1,135 $527,000
Q2 2024 Aug 05, 2024	BUY	$392.81 - $485.53 $3,928 - $4,855	10 Added 0.88%	1,151 $539,000
Q1 2024 May 07, 2024	BUY	$407.69 - $446.08 $40,769 - $44,608	100 Added 9.61%	1,141 $476,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $338 - $362	1 Added 0.1%	1,041 $361,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $566 - $646	-2 Reduced 0.19%	1,040 $327,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $571 - $642	2 Added 0.19%	1,042 $300,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $3,833 - $4,277	14 Added 1.36%	1,040 $301,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $4,699 - $5,851	-20 Reduced 1.91%	1,026 $289,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $12,399 - $14,614	56 Added 5.66%	1,046 $273,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $583,424 - $736,491	-3,296 Reduced 76.9%	990 $217,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $250,862 - $280,735	-1,383 Reduced 24.4%	4,286 $777,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $2.78 Million - $3.28 Million	-14,849 Reduced 72.37%	5,669 $1.14 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $1.21 Million - $1.41 Million	-5,846 Reduced 22.17%	20,518 $4.41 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $5.76 Million - $7.69 Million	-27,839 Reduced 51.36%	26,364 $6.23 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $13 Million - $15.4 Million	50,968 Added 1575.52%	54,203 $14.8 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $444,421 - $583,021	1,971 Added 155.93%	3,235 $939,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $61,928 - $76,821	310 Added 32.49%	1,264 $301,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $159,041 - $213,610	954 New	954 $209,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Williams Jones Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Williams Jones Wealth Management, Llc. with notifications on news.

Account

Williams Jones Wealth Management, Llc. Vertex Pharmaceuticals Inc Transaction History